Terms: = Liver cancer AND AKT2, PKBBETA, 208, ENSG00000105221, RAC-BETA, P31751, PRKBB AND Treatment
115 results:
1. Platelet-to-lymphocyte ratio predicts tumor response and survival of patients with hepatocellular carcinoma undergoing immunotherapies.
Wang ZY; Xu B; Wang LN; Zhu XD; Huang C; Shen YH; Li H; Li ML; Zhou J; Fan J; Sun HC
Int Immunopharmacol; 2024 Apr; 131():111863. PubMed ID: 38492340
[TBL] [Abstract] [Full Text] [Related]
2. All Three AKT Isoforms Can Upregulate Oxygen Metabolism and Lactate Production in Human Hepatocellular Carcinoma Cell Lines.
Tian LY; Smit DJ; Popova NV; Horn S; Velasquez LN; Huber S; Jücker M
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396845
[TBL] [Abstract] [Full Text] [Related]
3. Role of intravoxel incoherent motion (IVIM) imaging in response assessment of hepatocellular carcinoma after transarterial chemoembolization (TACE) - A prospective study.
Reddy Bursapalle M; Valakkadaa J; Ayappan A
Radiologia (Engl Ed); 2024; 66(1):23-31. PubMed ID: 38365352
[TBL] [Abstract] [Full Text] [Related]
4. Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month.
Chiu SH; Lin HH; Feng AC; Lo CH; Hsieh CB; Chen PK; Chang WC
Eur J Radiol; 2024 Jan; 170():111266. PubMed ID: 38185027
[TBL] [Abstract] [Full Text] [Related]
5. Analyzing risk factors and developing a stratification system for hepatocellular carcinoma recurrence after interferon-free direct-acting antiviral therapy in chronic hepatitis C patients.
Luan CH; Su PS; Chu CJ; Lin CC; Su CW; Luo JC; Lee IC; Chi CT; Lee SD; Wang YJ; Lee FY; Huang YH; Hou MC
J Chin Med Assoc; 2024 Apr; 87(4):357-368. PubMed ID: 38180018
[TBL] [Abstract] [Full Text] [Related]
6. Dose Volume and liver Function Test Relationship following Radiotheraphy for Right Breast cancer: A Multicenter Study.
Güzelöz Z; Ayrancıoğlu O; Aktürk N; Güneş M; Alıcıkuş ZA
Curr Oncol; 2023 Sep; 30(10):8763-8773. PubMed ID: 37887532
[TBL] [Abstract] [Full Text] [Related]
7. Impact of Surgical Management for Relapse After Conversion Hepatectomy for Initially Unresectable Colorectal liver Metastasis: A Retrospective Cohort Study.
Chen Y; Zhu D; Chen M; Xu Y; Ye Q; Wang X; Xu P; Feng Q; Ji M; Wei Y; Fan J; Xu J
Clin Colorectal Cancer; 2023 Dec; 22(4):464-473.e5. PubMed ID: 37730473
[TBL] [Abstract] [Full Text] [Related]
8. Transarterial interventional therapy combined with tyrosine kinase inhibitors with or without anti-PD-1 antibodies as initial treatment for hepatocellular carcinoma with major portal vein tumor thrombosis: a single-center retrospective study.
Yu W; Liu W; Zhang K; Chen S; Wang X
Cancer Immunol Immunother; 2023 Nov; 72(11):3609-3619. PubMed ID: 37566127
[TBL] [Abstract] [Full Text] [Related]
9. Graph-based automatic detection and classification of lesion changes in pairs of CT studies for oncology follow-up.
Rochman S; Szeskin A; Lederman R; Sosna J; Joskowicz L
Int J Comput Assist Radiol Surg; 2024 Feb; 19(2):241-251. PubMed ID: 37540449
[TBL] [Abstract] [Full Text] [Related]
10. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
[TBL] [Abstract] [Full Text] [Related]
11. Intercontinental comparison of women with breast cancer treated by oncologists in Europe, Asia, and Latin America: a retrospective study of 99,571 patients.
Kadys A; Gremke N; Schnetter L; Kostev K; Kalder M
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7319-7326. PubMed ID: 36920565
[TBL] [Abstract] [Full Text] [Related]
12. Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR.
Hsu PY; Liang PC; Huang CI; Hsieh MH; Tsai YS; Lin TC; Yeh ML; Huang CF; Wang CW; Jang TY; Lin YH; Lin ZY; Chuang WL; Dai CY
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366510
[TBL] [Abstract] [Full Text] [Related]
13. Clinical outcomes of curative surgical resection of peritoneal metastasis in patients with colorectal cancer: A long-term follow-up study.
Bang K; Kim JE; Kim TW; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Hong YS
Cancer Med; 2023 Feb; 12(3):2861-2868. PubMed ID: 36069152
[TBL] [Abstract] [Full Text] [Related]
14. Investigation of Vascular Endothelial Growth Factor Polymorphisms on Risk, Metastasis, Laterality, and Prognosis of Colorectal cancer in Turkish Subjects.
Cevik M; Namal E; Dinc-Sener N; Iner-Koksal U; Ciftci C; Susleyici B
Genet Test Mol Biomarkers; 2022 May; 26(5):298-306. PubMed ID: 35593899
[No Abstract] [Full Text] [Related]
15. Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate cancer.
Fonseca NM; Van der Eecken K; Herberts C; Verbeke S; Ng SWS; Lumen N; Ritch E; Murtha AJ; Bernales CQ; Schönlau E; Moris L; Van Dorpe J; Annala M; Wyatt AW; Ost P
JCO Precis Oncol; 2022 Apr; 6():e2100543. PubMed ID: 35507889
[TBL] [Abstract] [Full Text] [Related]
16. Using Real-world Data to Define a Validated Nomogram for Advanced Bladder cancer Patients Who Respond to Immunotherapy.
Elumalai T; Croxford W; Buijtenhuijs B; Conroy R; Sanderson B; Enting D; Aversa C; Doss G; Das A; Vasudev NS; Kitetere E; Tolan S; Law A; Hoskin P; Mistry H; Choudhury A
Clin Oncol (R Coll Radiol); 2022 Oct; 34(10):642-652. PubMed ID: 35282933
[TBL] [Abstract] [Full Text] [Related]
17. Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma.
Kaneko S; Kurosaki M; Tsuchiya K; Yasui Y; Hayakawa Y; Inada K; Tanaka Y; Ishido S; Kirino S; Yamashita K; Nobusawa T; Matsumoto H; Kakegawa T; Higuchi M; Takaura K; Tanaka S; Maeyashiki C; Tamaki N; Takahashi Y; Nakanishi H; Izumi N
PLoS One; 2022; 17(3):e0265235. PubMed ID: 35271670
[TBL] [Abstract] [Full Text] [Related]
18. Preoperative magnetic resonance imaging-based prognostic model for mass-forming intrahepatic cholangiocarcinoma.
Rhee H; Choi SH; Park JH; Cho ES; Yeom SK; Park S; Han K; Lee SS; Park MS
Liver Int; 2022 Apr; 42(4):930-941. PubMed ID: 35152534
[TBL] [Abstract] [Full Text] [Related]
19. Cost analysis of robotic versus open hepatectomy: Is the robotic platform more expensive?
Shapera E; Sucandy I; Syblis C; Crespo K; Ja'Karri T; Ross S; Rosemurgy A
J Robot Surg; 2022 Dec; 16(6):1409-1417. PubMed ID: 35152343
[TBL] [Abstract] [Full Text] [Related]
20. MiRNA-124-3p.1 sensitizes hepatocellular carcinoma cells to sorafenib by regulating FOXO3a by targeting akt2 and SIRT1.
Dong ZB; Wu HM; He YC; Huang ZT; Weng YH; Li H; Liang C; Yu WM; Chen W
Cell Death Dis; 2022 Jan; 13(1):35. PubMed ID: 35013144
[TBL] [Abstract] [Full Text] [Related]
[Next]
